Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Sep 18:14:1265603.
doi: 10.3389/fphar.2023.1265603. eCollection 2023.

Effectiveness of Shuxuening injection in coronary heart disease: a systematic review and meta-analysis

Menglong Shi #  1   2 , Tianye Sun #  3 , Zhaochen Ji  1   2 , Yucong Ma  1   2 , Min Zhao  4 , Fengwen Yang  1   2 , Junhua Zhang  1   2
Affiliations
Review

Effectiveness of Shuxuening injection in coronary heart disease: a systematic review and meta-analysis

Menglong Shi et al. Front Pharmacol. .

Abstract

Background: Coronary heart disease (CHD) poses a serious threat to public health, and the current medical management still faces significant challenges. Reliable evidence on the efficacy of Shuxuening injection (SXNI) in CHD is still lacking, even though it is widely used in China. Purpose: To evaluate the efficacy of SXNI combination therapy in treating CHD. Methods: A systematic search of eight databases was conducted to identify relevant randomized controlled trials (RCTs) from the inception of each database until June 2023. ROB 2.0, RevMan 5.4, and Stata 15.1 were used for quality evaluation and data analysis. The Grading of Recommendation, Assessment, Development, and Evaluation (GRADE) approach was used to evaluate the quality of evidence. Results: A total of 3,779 participants from 39 studies were included. The results showed SXNI combination therapy increased the clinical efficacy and decreased the frequency and duration of angina. Furthermore, SXNI combination therapy improved cardiac function of patients by decreasing LVEDD, and increased CI, CO, and LVEF. It also improved blood lipid profiles by increasing HDL, decreasing TC, TG, and LDL. The thrombosis factors of patients were also improved by decreasing FIB, PV, HCT, and HS. Moreover, SXNI combination therapy was superior to the conventional treatment in improving CRP levels, increasing ECG efficacy and BNP. However, due to the limited safety information, reliable safety conclusions could not be drawn. Furthermore, the levels of evidence ranged from very low to moderate due to publication bias and heterogeneity. Conclusion: SXNI can effectively improve angina symptoms, clinical efficacy, cardiac function, blood lipid indicators, and thrombosis factors of patients with CHD. However, more multi-center and large-sample studies are needed to confirm the conclusions due to the limitations of this study. Registration https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=399606; Identifier: CRD42023433292.

Keywords: Shuxuening injection; coronary heart disease; meta-analysis; randomized controlled trial; systematic review.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

None
Graphical abstract
FIGURE 1
FIGURE 1
PRISMA flow diagram of study selection process.
FIGURE 2
FIGURE 2
Risk of bias. (A) Risk of bias summary. (B) Risk of bias graph.
FIGURE 3
FIGURE 3
Effect of SXNI on clinical efficacy. (A) Forest plot of clinical efficacy. (B) Sensitivity analysis revealed the reliability of conclusion. (C) Funnel plots revealed the publication bias. (D) Egger’s test quantified the publication bias.
FIGURE 4
FIGURE 4
Subgroup analysis of the clinical efficacy.
FIGURE 5
FIGURE 5
Effect of SXNI on frequency of angina attack. (A) Forest plot of angina frequency. (B) Sensitivity analysis revealed the reliability of conclusion. (C) Funnel plots revealed the publication bias. (D) Egger’s test quantified the publication bias.
FIGURE 6
FIGURE 6
Effect of SXNI on angina symptoms. (A) Forest plot of angina duration. (B) Sensitivity analysis revealed the reliability of conclusion. (C) Meta-regression was used to find the sources of heterogeneity.
See this image and copyright information in PMC

References

    1. Boudoulas K. D., Triposciadis F., Geleris P., Boudoulas H. (2016). Coronary atherosclerosis: pathophysiologic basis for diagnosis and management. Prog. CARDIOVASC Dis. 58, 676–692. 10.1016/j.pcad.2016.04.003 - DOI - PubMed
    1. Cai H. (2021). Efficacy and safety of Shuxuening combined with atorvastatin in the treatment of angina pectoris after acute myocardial infarction. Sichuan J. Physiol. Sci. 43, 302–304.
    1. Chai J. (2010). Shuxuening combined with western medicine in treating 58 cases of unstable angina. FUJIAN J. Tradit. Chin. Med. 41, 20–21. 10.3969/j.issn.1000-338X.2010.03.011 - DOI
    1. Chen B., Chen X., Liang S. (2016). Clinical effect analysis of Shuxuening injection combined with nitroglycerin injection on angina pectoris of coronary heart disease. Chin. Prac. Med. 11, 148–149. 10.14163/j.cnki.11-5547/r.2016.20.094 - DOI
    1. Cui S., An A., Hao X., Zhao X., Gong J. (2008). Curative effect of shuxuening injection on angina pectoris. Eval. Anal. Drug-Use Hosp. Chin 8, 687–688. 10.3969/j.issn.1672-2124.2008.09.020 - DOI